These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2494270)

  • 1. Effect of tissue-type plasminogen activator (t-PA) on the treatment with benzylpenicillin of rabbits with experimental Streptococcus sanguis endocarditis.
    Buiting AG; Thompson J; Emeis JJ; Mattie H; Brommer EJ; van Furth R
    J Infect Dis; 1989 Apr; 159(4):780-4. PubMed ID: 2494270
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tissue-type plasminogen activator (t-PA) on Streptococcus sanguis-infected endocardial vegetations in vitro.
    Buiting AG; Thompson J; Emeis JJ; Mattie H; Brommer EJ; van Furth R
    J Antimicrob Chemother; 1988 May; 21(5):609-20. PubMed ID: 3134321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental endocarditis caused by Streptococcus sanguis: single and combined antibiotic therapy.
    Vicente MV; Olay T; Rodríguez A
    Antimicrob Agents Chemother; 1981 Jul; 20(1):10-4. PubMed ID: 7283409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response to benzylpenicillin in vivo of tolerant and non-tolerant variants of Streptococcus sanguis II.
    Meeson J; McColm AA; Acred P; Greenwood D
    J Antimicrob Chemother; 1990 Jan; 25(1):103-9. PubMed ID: 2318747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial endocarditis due to penicillin-resistant Streptococcus viridans.
    McCarthy VP; Cho CT; Diehl AM; Ramsey BW
    Clin Pediatr (Phila); 1979 May; 18(5):263-6. PubMed ID: 109241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic anemia in a patient with subacute bacterial endocarditis due to Streptococcus sanguis.
    Inada T; Shirono K; Tsuda H
    Acta Haematol; 1995; 94(2):95-7. PubMed ID: 7484020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin tolerance in experimental streptococcal endocarditis.
    Pulliam L; Inokuchi S; Hadley WK; Mills J
    Lancet; 1979 Nov; 2(8149):957. PubMed ID: 91047
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin.
    Martínez F; Martín-Luengo F; García A; Valdés M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):247-51. PubMed ID: 8051983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with imipenem of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis.
    Martínez F; Martín-Luengo F; Garcia A; Valdés M
    J Antimicrob Chemother; 1994 Jun; 33(6):1201-7. PubMed ID: 7928813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus viridans].
    Gavaldà J; Pahissa A; Almirante B
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):174-6. PubMed ID: 8011732
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits.
    Meddens MJ; Thompson J; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1984 Feb; 25(2):263-7. PubMed ID: 6712203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.
    Durack DT; Pelletier LL; Petersdorf RG
    J Clin Invest; 1974 Mar; 53(3):829-33. PubMed ID: 4492776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental endocarditis in rabbits. 7. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and gentamicin.
    Gutschik E
    Acta Pathol Microbiol Immunol Scand B; 1982 Aug; 90(4):295-302. PubMed ID: 6814183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocarditis caused by nutritionally-variant streptococci: therapy with penicillin combined initially with gentamicin.
    Dworzack DL; Clark RB; Pugsley MP; Stanosheck JF; Dehning MM
    Nebr Med J; 1986 May; 71(5):118-21. PubMed ID: 3713907
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of experimental streptococcal endocarditis. V. Effect of duration of infection and retained intracardiac catheter on response to treatment.
    Pelletier LL; Petersdorf RG; Nielson K
    J Lab Clin Med; 1976 Apr; 87(4):692-702. PubMed ID: 1270880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advantage of recombinant human plasminogen activator in endocarditis: evidence from experiments in rabbits.
    Meyer MW; Witt AR; Krishnan LK; Yokota M; Roszkowski MJ; Rudney JD; Herzberg MC
    Thromb Haemost; 1995 Apr; 73(4):680-2. PubMed ID: 7495078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of warfarin on the induction and course of experimental endocarditis.
    Thompson J; Eulderink F; Lemkes H; van Furth R
    Infect Immun; 1976 Dec; 14(6):1284-9. PubMed ID: 1002298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial therapy of vitamin B6-dependent streptococcal endocarditis.
    Carey RB; Brause BD; Roberts RB
    Ann Intern Med; 1977 Aug; 87(2):150-4. PubMed ID: 889195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relatively penicillin-resistant Streptococcus sanguis endocarditis in an adolescent.
    Boenning DA; Nelson LP; Campos JM
    Pediatr Infect Dis J; 1988 Mar; 7(3):205-7. PubMed ID: 3357720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.